13:20 GMT15 June 2021
Listen Live
    Get short URL

    WASHINGTON, (Sputnik) - United States Trade Representative (USTR) Katherine Tai has discussed a patent waiver on COVID-19 vaccines in a virtual meeting with World Health Organization (WHO) Director General Dr. Tedros Adhanom Ghebreyesus, the USTR said on Friday.

    "...Tai today met virtually with ... Director-General of the WHO to discuss increasing vaccine production, and the proposed waiver to certain provisions of the World Trade Organization’s (WTO) Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS) for the COVID-19 pandemic," the USTR said in a readout.

    Tai explained the Biden administration’s support for the waiver of intellectual property protections for COVID-19 vaccines and the administration’s comprehensive effort to expand vaccine manufacturing and distribution around the world, the USTR said.

    Tai and Adhanom Ghebreyesus also agreed to stay in regular communication in the days ahead, the USTR added.

    More than 80 countries, led by India and South Africa, are attempting to persuade the World Trade Organization to waive the Trade-Related Aspects of Intellectual Property (TRIPS) agreement, which has significantly limited Third World countries' ability to produce generic copies of drugs since 1995, forcing them to buy from the First World at rates that are often prohibitively high even for citizens in the United States or Europe.


    Bill Gates Rejects COVID-19 Vaccine Patent Waivers as Shot-Maker India Buckles Under Second Wave
    WHO Expects to Complete Safety Assessment of Russia's Sputnik V Vaccine by July
    Germany Rejects US Proposal to Waive COVID-19 Patents, Warns of ‘Severe Complications’
    WHO Deems COVID-19 Strain Found in India ‘Variant of Concern’
    patent, US patents, Vaccines, vaccine, coronavirus, COVID-19, World Health Organization (WHO), Doctor Who, USA, US
    Community standardsDiscussion